arxiv: 2603.13464 · v2 · submitted 2026-03-13 · 📊 stat.ME

Recognition: no theorem link

Modeling Heterogeneous Mediation Effects in Survival Analysis via an Interpretable M-Learner Framework

Xingyu Li , Qing Liu , Xun Jiang , Hong Amy Xia , Brian P. Hobbs , Peng Wei

Authors on Pith no claims yet

Pith reviewed 2026-05-15 11:20 UTC · model grok-4.3

classification 📊 stat.ME

keywords mediation analysissurvival analysisheterogeneous effectsM-learnersurrogate endpointscensored datapatient subgroupsindirect treatment effects

0 comments

The pith

The M-survival learner estimates heterogeneous indirect treatment effects in censored survival data to identify patient subgroups with distinct mediation pathways.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

This paper develops the M-survival learner to estimate how treatment effects on survival outcomes are mediated differently across patient subgroups when data include censoring. Heterogeneous mediation matters in clinical trials because surrogate endpoints must work consistently across groups to justify accelerated drug approvals. The method adds a new statistical criterion built for survival data that separates cases of varying mediation from uniform ones. It supplies theoretical properties for validity and shows results on a Phase III HIV treatment trial plus simulation checks. The outcome is a framework that directly evaluates surrogate biomarker performance in diverse patient populations.

Core claim

The M-survival learner provides a principled framework for modeling heterogeneous mediation effects in survival analysis with censored outcomes, enabling identification of interpretable patient subgroups characterized by distinct mediation pathways through a new statistical criterion designed for survival data, along with theoretical guarantees and demonstration on HIV trial data.

What carries the argument

The M-survival learner, an interpretable framework that estimates subgroup-specific indirect treatment effects while handling censoring and using a dedicated statistical criterion to detect mediation heterogeneity.

If this is right

The method identifies interpretable patient subgroups characterized by distinct mediation pathways in censored survival data.
It evaluates heterogeneity in surrogate biomarker performance to support accelerated drug approval decisions.
Theoretical properties establish statistical guarantees for the estimates.
Application to Phase III HIV trial data demonstrates practical utility.
Simulation studies confirm finite-sample performance of the approach.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

The criterion could be tested in oncology or cardiovascular trials with different censoring patterns to check broader applicability.
Future checks on data with injected unmeasured confounding would show where identification breaks.
Pairing the learner with existing causal tools might reduce reliance on the no-confounding assumption for pathway discovery.
Subgroup findings may support development of tailored surrogate endpoints for specific patient groups.

Load-bearing premise

The new statistical criterion reliably distinguishes heterogeneous from homogeneous mediation effects under standard survival censoring without unmeasured confounding or model misspecification.

What would settle it

A dataset with known heterogeneous mediation patterns where the M-survival learner fails to recover the correct subgroups or misclassifies mediation types.

read the original abstract

Mediation analysis is a useful tool to evaluate surrogate endpoints in clinical trials. We propose a novel method, the M-survival learner, for estimating heterogeneous indirect treatment effects in the presence of censored outcomes. The proposed approach enables the identification of interpretable patient subgroups characterized by distinct mediation pathways. To distinguish heterogeneous from homogeneous mediation effects, we introduce a new statistical criterion specifically designed for survival data. The method provides a principled framework for evaluating heterogeneity in surrogate biomarker performance across patient populations, offering evidence to support accelerated approval drug. By explicitly assessing subgroup-specific surrogate validity, the proposed approach addresses key regulatory concerns regarding the reliability of surrogate endpoints. We further establish theoretical properties of the method to justify its statistical guarantees. We apply the approach to data from a Phase III randomized clinical trial of HIV treatment, demonstrating its practical utility in real-world settings. Extensive simulation studies further evaluate and demonstrate its finite-sample performance.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Desk Editor's Note private letter to a colleague

The M-survival learner adds a concrete adaptation for spotting mediation heterogeneity in censored data, useful for surrogate checks in trials, but its criterion lacks shown robustness to common violations like dependent censoring.

read the letter

The paper's main new piece is the M-survival learner that estimates subgroup-specific indirect effects under censoring, paired with a survival-tailored criterion to flag when mediation pathways differ across patients. This targets a practical need in clinical trials where surrogates may perform unevenly, and the HIV data example plus simulations give it a workable demonstration. The focus on interpretable subgroups is a clear strength for regulatory contexts around accelerated approvals. The theoretical claims are stated, which helps if the derivations hold. The soft spot is exactly what the stress-test flags: no visible sensitivity runs for dependent censoring, mediator misspecification, or unmeasured confounding. Without those, the new criterion risks mistaking censoring patterns or model error for true heterogeneity, and the abstract gives no equations or exclusion details to judge how the method avoids that. Standard sequential ignorability is assumed but not probed under realistic breaks. This is for biostatisticians and trial methodologists who already work with survival mediation and want a tool to check subgroup surrogate validity. A reader in that area can extract a usable framework and test it themselves. It deserves peer review because the idea fills a documented gap with simulations and real data, even if revisions will be needed on the validation side.

Referee Report

2 major / 2 minor

Summary. The manuscript proposes the M-survival learner, a novel framework for estimating heterogeneous indirect treatment effects in survival analysis with right-censored outcomes. It introduces a new statistical criterion to distinguish heterogeneous from homogeneous mediation effects, claims theoretical properties justifying statistical guarantees, and evaluates the method via simulation studies plus an application to Phase III HIV trial data for assessing subgroup-specific surrogate endpoint validity.

Significance. If the central claims hold, the work would address a relevant gap in mediation analysis for censored survival data and surrogate endpoint evaluation in clinical trials. The ability to identify interpretable patient subgroups with distinct mediation pathways could support regulatory assessments of surrogate biomarkers, provided the method demonstrates robustness beyond standard assumptions.

major comments (2)

[Simulation studies] Simulation studies section: no sensitivity analyses are reported that inject dependent censoring, unmeasured mediator-outcome confounding, or mediator-model misspecification and then re-evaluate whether the new statistical criterion still correctly flags heterogeneous mediation or whether the estimated indirect effects remain stable; this is load-bearing for the claim that the criterion reliably distinguishes heterogeneous from homogeneous effects under realistic survival censoring.
[Theoretical properties] Theoretical properties section: the abstract asserts theoretical properties and statistical guarantees, yet the provided text contains no explicit derivation steps, identification assumptions (e.g., sequential ignorability plus independent censoring), or equations showing how the M-learner recovers subgroup-specific indirect effects; without these the support for the central claim cannot be verified.

minor comments (2)

[Abstract] Abstract: error-bar details, exclusion rules, and finite-sample performance metrics are not summarized, making it difficult to assess the strength of the simulation and real-data results.
[Methods] Notation: the manuscript should clarify how the new statistical criterion is computed from the fitted M-learner quantities and whether it reduces to existing mediation contrasts under homogeneity.

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for the constructive and detailed comments. We address each major point below and will revise the manuscript to incorporate the suggested improvements.

read point-by-point responses

Referee: [Simulation studies] Simulation studies section: no sensitivity analyses are reported that inject dependent censoring, unmeasured mediator-outcome confounding, or mediator-model misspecification and then re-evaluate whether the new statistical criterion still correctly flags heterogeneous mediation or whether the estimated indirect effects remain stable; this is load-bearing for the claim that the criterion reliably distinguishes heterogeneous from homogeneous effects under realistic survival censoring.

Authors: We agree that sensitivity analyses are essential to support the robustness claims for the new criterion. In the revised manuscript we will add simulation scenarios that introduce dependent censoring, unmeasured mediator-outcome confounding, and mediator-model misspecification. For each scenario we will report the criterion's ability to correctly flag heterogeneity and the stability of the estimated indirect effects. revision: yes
Referee: [Theoretical properties] Theoretical properties section: the abstract asserts theoretical properties and statistical guarantees, yet the provided text contains no explicit derivation steps, identification assumptions (e.g., sequential ignorability plus independent censoring), or equations showing how the M-learner recovers subgroup-specific indirect effects; without these the support for the central claim cannot be verified.

Authors: We acknowledge that the theoretical development must be presented more explicitly. The revised manuscript will contain a dedicated section (or appendix) that states the identification assumptions (sequential ignorability and independent censoring), provides the key derivation steps, and displays the equations that establish how the M-learner recovers subgroup-specific indirect effects. revision: yes

Circularity Check

0 steps flagged

No circularity detected in derivation chain

full rationale

The paper introduces the M-survival learner and a new statistical criterion for heterogeneous mediation in censored survival data as extensions of existing mediation methods. No equations, fitted parameters, or self-citations are exhibited that reduce the claimed subgroup identification or indirect effects back to the inputs by construction. Theoretical properties are stated as independently established, and performance is evaluated via simulations and an HIV trial application without evidence of self-definitional loops, fitted-input predictions, or load-bearing self-citations. The derivation chain remains self-contained against external benchmarks.

Axiom & Free-Parameter Ledger

0 free parameters · 1 axioms · 0 invented entities

The central claim rests on standard mediation and survival-analysis assumptions plus the validity of the newly introduced criterion; no free parameters, invented entities, or explicit axioms are enumerated in the abstract.

axioms (1)

domain assumption Standard assumptions of no unmeasured confounding and correct specification of the censoring mechanism hold for the mediation model.
Typical background requirement for mediation analysis in survival data; implied by the proposal but not stated explicitly.

pith-pipeline@v0.9.0 · 5462 in / 1330 out tokens · 31253 ms · 2026-05-15T11:20:36.226947+00:00 · methodology

discussion (0)

Reference graph

Works this paper leans on

19 extracted references · 19 canonical work pages

[1]

This representation has direct 22 Biometrics, December 2006 implications for precision treatment strategies and for the design of adaptive or subgroup-enriched clinical trials

ensions of patient characteristics rather than relying on ad hoc subgroup definitions, the method yields a more interpretable and clinically meaningful characterization of heterogeneity. This representation has direct 22 Biometrics, December 2006 implications for precision treatment strategies and for the design of adaptive or subgroup-enriched clinical t...

work page 2006
[2]

R., Perrin, L., Pantaleo, G., Opravil, M., Furrer, H., Telenti, A., Hirschel, B., Ledergerber, B., Vernazza, P., Bernasconi, E., et al

Kaufmann, G. R., Perrin, L., Pantaleo, G., Opravil, M., Furrer, H., Telenti, A., Hirschel, B., Ledergerber, B., Vernazza, P., Bernasconi, E., et al. (2003). Cd4 t-lymphocyte recovery in individuals with advanced hiv-1 infection receiving potent antiretroviral therapy for 4 years: the swiss hiv cohort study. Archives of internal medicine 163, 2187–2195. Ka...

work page 2003
[3]

Panels (a)–(c) depict three scenarios of surrogate relationships

26 Biometrics, December 2006 Figure 1: Causal diagrams for surrogate endpoint validation and mediation model. Panels (a)–(c) depict three scenarios of surrogate relationships. These scenarios provide illustrative examples for the analytical workflow presented in panel (d). (a) represents an ideal surrogate scenario, in which the surrogate endpoint M fully...

work page 2006
[4]

Black points denote replicate-specific estimates, and the red curves represent the corresponding density estimates

Each point represents the estimated boundary threshold of the mediator-heterogeneous region obtained from the selected profile in a single simulation replicate. Black points denote replicate-specific estimates, and the red curves represent the corresponding density estimates. Scenarios All1 and All2 correspond to complete mediation of the treatment effect...

work page 2006
[5]

Details on the construction of the counterfactual survival plots are provided in Appendix I. 1 Supporting Information for Modeling Heterogeneous Mediation Effects in Survival Analysis via an Interpretable M-Learner Framework by Xingyu Li, Qing Liu, Xun Jiang, Hong Amy Xia, Brian P. Hobbs, and Peng Wei Web Appendix A: Heterogeneous mediation treatment effe...

work page 2011
[6]

Under Assumptions S1–S2 and for a suitable choice of the regularization pa-rameter λ, the kernel estimator satisfies where R(ϕˆM1 ) = O˜P 2α p+2α , R(f ) = E (f (X) − ϕM (X))2 and O˜P (·) hides logarithmic factors. In particular, ϕˆM1 — ϕM1 2 L2(P ) = O˜P 2α p+2α , which the rate was established in [Mendelson and Neeman, 2010] and the suitable choice of t...

work page 2010
[7]

Formally, consider a supervised learning framework with n training samples {X1,

showed that supervised clustering substantially outperforms unsupervised meth-ods such as K-means and hierarchical clustering. Formally, consider a supervised learning framework with n training samples {X1, . . . , Xn}, each characterized by p baseline covari-ates, corresponding outcomes Y1, . . . , Yn , and surrogate biomarkers M1, . . . , Mn . In our fr...

work page 2026
[8]

ground-truth

analyzed the theoretical properties of the original t-SNE under a regime in which the number of clusters is allowed to grow with the sample size n, our analysis fo-cuses on a fundamentally different setting motivated by clinical applications. Specifically, we study a modified t-SNE procedure in which pairwise dissimilarities are defined based on similarit...

work page 2018
[9]

intra-cluster distances

γ-well-sparated: For any l, l ∈ [k](l ̸= l ), i ∈ Cl and j ∈ Cl′ we have (vi − vj)2 ≥ (1 + γ log n) max{bl, bl′ }. 11 Σ Σ Σ − 4 Σ i i j i The first condition asks for the distances between points in the same cluster (“intra-cluster distances”) to be concentrated around a single value (with controlling the “amount” of concentration). The second condition r...

work page 1999
[10]

In a two-dimensional map Y = {y1, · · · , yn} ⊂ R2, define the affinity qij between points yi and yj (i ̸= j) as (1 + yi − yj 2)−1 qij = Σl,s∈[n],l̸=s(1 + yl − ys 2)−1

, (9) 2n where τi is a tunable parameter that controls the bandwidth of the Gaussian kernel around point vi. In a two-dimensional map Y = {y1, · · · , yn} ⊂ R2, define the affinity qij between points yi and yj (i ̸= j) as (1 + yi − yj 2)−1 qij = Σl,s∈[n],l̸=s(1 + yl − ys 2)−1 . (10) The t-SNE tries to find points yi’s in R2 that minimize the KL-divergence...

work page 2014
[11]

For spherical and well-separated data, our theorem below shows that t-SNE with early exaggeration succeeds in finding a full visualization

supports the phenomenon by theoretical analysis. For spherical and well-separated data, our theorem below shows that t-SNE with early exaggeration succeeds in finding a full visualization. In the early exaggeration, all pij’s are multipled by a factor α > 1 [Van der Maaten and Hinton, 2008]. Letting the step size in the gradient descent method be h, we ge...

work page 2008
[12]

Theorem S2 indicated that, in the presence of heterogeneity in the surrogate, t-SNE can project the subgroup structure encoded in the dissimilarity matrix constructed from pairwise differences in NIECC, into a two-dimensional space. As noted in Cai and Ma [2022], during the t-SNE embedding step, the resulting clusters are reliable in terms of their member...

work page 2022
[13]

Then, pij’s satisfy (1)-(4) in Lemma S1 with δ = Θ(α/n), ϵ = 2/n and η = 0.01

with parameters τ 2 = γ minj∈[n]\{i}(τi − τj)2(∀i ∈ [n]), h = 1, and any α satisfying α = o(n), and i 4 n log n = o(α). Then, pij’s satisfy (1)-(4) in Lemma S1 with δ = Θ(α/n), ϵ = 2/n and η = 0.01. 5.1 Proof of Lemma S1 The proof of Lemma S1 is naturally divided into two parts. In the first part, we establish that over the course of the iterative updates...

work page 2019
[14]

(1) b # 1 2b √ for any a ∈ R. For any l′ ̸= l, because µ(1) and µ(1) are independent, we can let a = µ(1) in the last equation, which tell us l l′ l′ P

Suppose |Cl| ≥ 0.1(n/k) for all l ∈ [k]. If yi,(0)’s are generated i.i.d from the uniform distribution over [−0.01, 0.01] , then with probability at least 0.99 we have ′ √ µl,(0) − µl′ ,(0) = Ω( n ) for all l ̸= l . For notational simplicity, the superscript “(0)” is suppressed in the proof of this lemma. For a vector y, denoted by y(1) its first coordina...

work page 1941
[15]

To prove the Lemma S6, we need the following Lemma

Under the same setting as Lemma S1, for all t ≤ 0.01 and all l ∈ [k] we have µl,(t+1) µl,(t) ϵ. To prove the Lemma S6, we need the following Lemma. Lemma S 7 (Claim A.4 in [Arora et al., 2018]). Under the setting as Lemma S1, for all t ≤ 0.01 , we have yi,(t) ∈ [−0.02, 0.02]2 and ϵi,(t) ≤ ϵ for all i ∈ [n]. P = k/n) = k/n). P k/n) ≤ 0.01 (28) ! ′ 21 ϵ ∈ C...

work page 2018
[16]

5.4 Proof of Lemma S3 Lemma S 9 (Lemma 1 in [Linderman and Steinerberger, 2019])

Therefore we have finished the proof of Lemma S2. 5.4 Proof of Lemma S3 Lemma S 9 (Lemma 1 in [Linderman and Steinerberger, 2019]). Let z1, , zm Rs be evolving as the following dynamic system: m zi,(t+1) = λij,(t)zj,(t) + ϵi,(t), i ∈ [m], t = 0, 1, 2, · · · (36) j=1 where zi,(t) is the position of zi at time t. Denote by Conv(t) the convex hull of z1,(Σt)...

work page 2019
[17]

Sanjeev Arora, Wei Hu, and Pravesh K Kothari

doi: 10.1214/105051604000000512. Sanjeev Arora, Wei Hu, and Pravesh K Kothari. An analysis of the t-sne algorithm for data visualization. In Conference on learning theory, pages 1455–1462. PMLR,

work page doi:10.1214/105051604000000512
[18]

Unsuper-vised dense random survival forests identify interpretable patient profiles with heteroge-neous treatment benefit

Xingyu Li, Qing Liu, Tony Jiang, Hong Amy Xia, Peng Wei, and Brian P Hobbs. Unsuper-vised dense random survival forests identify interpretable patient profiles with heteroge-neous treatment benefit. arXiv preprint arXiv:2601.01380,

work page arXiv
[19]

doi: 10.1214/09-aos728

ISSN 0090-5364. doi: 10.1214/09-aos728. URL http: //dx.doi.org/10.1214/09-AOS728. Xinkun Nie and Stefan Wager. Quasi-oracle estimation of heterogeneous treatment effects. Biometrika, 108(2):299–319,

work page doi:10.1214/09-aos728